Morgan Stanley’s GeoVax Labs GOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.54K Buy
2,003
+1,997
+33,283% +$3.04K ﹤0.01% 7358
2026
Q1
$8 Buy
6
+1
+20% +$2 ﹤0.01% 8219
2025
Q4
$21 Sell
5
-1,000
-100% -$11K ﹤0.01% 8073
2025
Q3
$11.9K Sell
1,005
-1,000
-50% -$17.5K ﹤0.01% 6853
2025
Q2
$43.4K Sell
2,005
-2,082
-51% -$51.9K ﹤0.01% 6407
2025
Q1
$108K Buy
4,087
+4,082
+81,640% +$180K ﹤0.01% 5972
2024
Q4
$296 Sell
5
-25
-83% -$1.45K ﹤0.01% 7382
2024
Q3
$1.84K Sell
30
-26
-46% -$2.19K ﹤0.01% 7147
2024
Q2
$4.47K Buy
56
+51
+1,020% +$2.24K ﹤0.01% 6876
2024
Q1
$240 Sell
5
-6
-55% -$473 ﹤0.01% 7296
2023
Q4
$1.47K Sell
11
-123
-92% -$21.5K ﹤0.01% 7169
2023
Q3
$25.8K Hold
134
﹤0.01% 6407
2023
Q2
$27.6K Hold
134
﹤0.01% 6445
2023
Q1
$33.4K Sell
134
-19
-12% -$5.33K ﹤0.01% 6435
2022
Q4
$36.1K Buy
153
+17
+13% +$5.16K ﹤0.01% 6433
2022
Q3
$56K Buy
136
+128
+1,600% +$73.8K ﹤0.01% 6357
2022
Q2
$2K Sell
8
-5
-38% -$2.2K ﹤0.01% 7584
2022
Q1
$6K Hold
13
﹤0.01% 7539
2021
Q4
$18K Buy
13
+8
+160% +$11.9K ﹤0.01% 7249
2021
Q3
$7K Buy
5
+1
+25% +$1.74K ﹤0.01% 7419
2021
Q2
$7K Hold
4
﹤0.01% 7311
2021
Q1
$7K Buy
+4
New +$7.78K ﹤0.01% 7029

Other funds holding GOVX

Morgan Stanley's GOVX Position: Q2 2026 in Review

Morgan Stanley increased its GeoVax Labs (GOVX) stake by 33,283% in Q2 2026, buying an estimated $3.04K and bringing the position to 2,003 shares worth $2.54K. The position accounts for ﹤0.01% of the portfolio, ranked #7358.

Morgan Stanley first reported a position in GOVX in Q1 2021 and has held it in 22 quarters since. The position peaked at $108K in Q1 2025. 11 funds tracked by Wall St. Rank hold GOVX as of Q2 2026.

  • Morgan Stanley held 2,003 shares of GeoVax Labs worth $2.54K as of Q2 2026.
  • Morgan Stanley bought 1,997 GeoVax Labs shares in Q2 2026, an estimated $3.04K.
  • GeoVax Labs made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7358 holding.
  • Morgan Stanley first reported a position in GeoVax Labs in Q1 2021 and has held it in 22 quarters since.
  • Morgan Stanley's GeoVax Labs position peaked at $108K in Q1 2025.
  • 11 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.